Scientists probe Cortisol's role in rare fat disease
NCT ID NCT04845165
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looked at how the body handles the hormone cortisol in people with a rare genetic condition called familial partial lipodystrophy type 2 (FPL2). The goal was to see if a specific enzyme that reactivates cortisol is more active in these patients, which might contribute to their severe metabolic issues. Researchers measured cortisol-related substances in urine and fat tissue from 25 participants. The study did not test any treatment, but aimed to better understand the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL PARTIAL LIPODYSTROPHY TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hop Claude Huriez
Lille, 59037, France
Conditions
Explore the condition pages connected to this study.